Advertisement

Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infection

Authors


  • Potential conflict of interest: Dr. Lim consults for and received grants from Bristol-Myers Squibb, Boehringer Ingelheim, Gilead, and Vertex. He received grants from Abbott, GlaxoSmithKline, Janssen, and Roche. He consults for Merck.

Ancillary